Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The study tests the notion that patients suffering from certain types of congenital
myasthenic syndromes are benefitted by the use of Albuterol at doses used in clinical
practice.